FORWARD FEATURES CALENDAR

Deals

Main Capital Partners acquires RiskConcile

Main Capital Partners has made its first Belgian platform investment with the acquisition of a majority stake in RiskConcile, a Belgian software provider of regulatory and risk solutions for the financial industry.

Inflexion to sell ITM

European mid-market private equity firm Inflexion is to sell its investment in ITM, a data services and technology provider for the pensions market, to Lumera, a Sweden-based, private equity-backed insuretech company.

PAI Partners and Inveready team up to make Avatel bid

French private equity firm PAI Partners and Spanish investment firm Inveready have collaborated on a bid for Avatel, Spain’s fifth-largest telecoms company, according to a report by Expansion, citing unidentified market sources.

Partners Group acquires majority stake in €900m biotech FairJourney

Swiss private equity firm Partners Group has acquired a majority stake in FairJourney Biologics, a biotech known for its work on antibody treatments for major drugmakers such as Johnson & Johnson, in a deal that values the business at €900m, according to a report by the Financial Times.

Events

12 November, 2026 – 5:00 pm

Directory Listings